Steve Senneff - 16 Nov 2021 Form 4 Insider Report for Signify Health, Inc. (SGFY)

Role: Pres. Chief Fin. & Admin. Off.
Signature: /s/ Adam McAnaney as Attorney-in-Fact for Steve Senneff
Issuer symbol: SGFY
Transactions as of: 16 Nov 2021
Transactions value $: $302,400
Form type: 4
Filing time: 18 Nov 2021, 17:23:02
Next filing: 23 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGFY	Class A Common Stock	Purchase	$153K	+10K	+8.92%	$15.32	122K	16 Nov 2021	Direct	F1
transaction	SGFY	Class A Common Stock	Purchase	$149K	+10K	+8.19%	$14.92	132K	17 Nov 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.29 to $15.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.77 to $15.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.29 to $15.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.77 to $15.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.